BELBEL CAESAR J 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 3, 2018
Insider Transaction Report
Form 4
BELBEL CAESAR J
EVP, Chief Legal Officer & Sec
Transactions
- Award
Common Stock
2017-12-29+87,000→ 260,551 total - Tax Payment
Common Stock
2017-12-30$4.14/sh−31,450$130,203→ 229,101 total - Tax Payment
Common Stock
2017-12-31$4.14/sh−21,667$89,701→ 207,434 total
Footnotes (2)
- [F1]29,000 shares shall vest on each of 12/29/2018, 12/29/2019 and 12/29/2020.
- [F2]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.